(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MARY'S MEDICINALS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

MARY'S MEDICINALS

ST13

US500000088982266

Class

41

Filing

88982266

Registration

6480118

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

10/17/2022

Trademark type

Combined

Nice classes

41

Filing date

07/23/2018

Registration date

09/07/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/07/2021

Last transaction

10/17/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

07/02/2018

First use in commerce

07/02/2018

Drawing code

5

Owner type

16

Owner location

DENVER, CO, US

Examiner

CAHILL, CLARE GALLAGHER

Law office

L40

Current location

TMEG LAW OFFICE 104

Mark description

The mark consists of the word "MARY'S" in script with the word "MEDICINALS" in block letters below the word "MARY'S".

Holders and representatives

Holders

MM TECHNOLOGY HOLDINGS, LLC
Mary's Medicinals LLC

Representatives

Claudia W. Stangle LEYDIG, VOIT & MAYER, LTD.

Technical classification

Nice Classes

Class 41

Vienna Codes

No Vienna codes available.

Goods and services

Class 41

Providing informationnewscommentary in the field of current events relating to cannabismarijuanahemp and subject matter related to cannabismarijuanahemp

Publications

History of USPTO decisions and trademark events.

38 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

01/12/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

09/07/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/05/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/04/2021

DOCK

ASSIGNED TO EXAMINER

07/12/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/07/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

07/06/2021

DPCC

DIVISIONAL PROCESSING COMPLETE

07/06/2021

EX2G

SOU EXTENSION 2 GRANTED

07/06/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

06/22/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/29/2021

IUAF

USE AMENDMENT FILED

03/19/2021

DRRR

DIVISIONAL REQUEST RECEIVED

03/19/2021

EXT2

SOU EXTENSION 2 FILED

03/19/2021

EISU

TEAS STATEMENT OF USE RECEIVED

03/19/2021

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

03/19/2021

EEXT

SOU TEAS EXTENSION RECEIVED

03/19/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/18/2020

EX1G

SOU EXTENSION 1 GRANTED

09/16/2020

EXT1

SOU EXTENSION 1 FILED

09/16/2020

EEXT

SOU TEAS EXTENSION RECEIVED

09/16/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/07/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/11/2020

PUBO

PUBLISHED FOR OPPOSITION

02/11/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/22/2020

ALIE

ASSIGNED TO LIE

01/06/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/31/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/28/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/28/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/28/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/01/2019

GNRT

NON-FINAL ACTION E-MAILED

07/01/2019

CNRT

NON-FINAL ACTION WRITTEN

07/01/2019

DOCK

ASSIGNED TO EXAMINER

06/24/2019

DOCK

ASSIGNED TO EXAMINER

08/08/2018

DOCK

ASSIGNED TO EXAMINER

08/07/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/27/2018

NWAP

NEW APPLICATION ENTERED

07/26/2018

Continuous trademark protection

Get notified about every new filing that threatens MARY'S MEDICINALS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.